首页 > 市场调查报告书 > 医疗设备

电子医疗设备

市场调查报告书

商品编码

1879395

脊椎手术后症候群（FBSS）治疗设备市场报告：趋势、预测和竞争分析（至2031年）

Failed Back Surgery Syndrome Treatment Device Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年11月26日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

由于医院和门诊手术中心市场存在机会，全球脊椎手术后症候群 (FBSS) 治疗设备市场前景广阔，预计 2025 年至 2031 年的复合年增长率将达到 7.5%。该市场的主要驱动因素是腰痛盛行率的增加、对非侵入性治疗方法需求的增长以及脊椎技术的进步。

根据 Lucintel 的预测，在各种类型中，脊髓刺激设备预计将在预测期内呈现较高的成长率。
在各类应用领域中，预计门诊手术中心将呈现更高的成长率。
从区域来看，预计亚太地区在预测期内将达到最高的成长率。

脊椎手术后症候群（FBSS）治疗设备市场的新兴趋势

脊椎手术后疼痛症候群 (FBSS) 治疗设备市场正受到几个关键趋势的显着影响，发生巨大变革。这些趋势正引领市场超越传统的疼痛管理模式，转向更全面、技术化和以患者为中心的策略。其重点在于开发更有效、更不创伤、更特异性的解决方案，以应对复杂且棘手的临床病症。

微创经皮植入：微创经经皮植入技术正逐渐应用于脊髓刺激设备等医疗器材的植入，与开放性手术相比，该技术可最大限度地减少手术创伤、缩短恢復时间并降低併发症。各公司正在研发更小巧、更灵活的植入，这些植入物可透过单一小切口植入。这种治疗方法耐受性更好、安全性更高，因此越来越受到医生和患者的欢迎，并推动了这些器械的广泛应用。
先进的神经调控波形：一种新兴趋势是开发复杂的神经调控波形，包括高频和脉衝串刺激。与传统的连续刺激不同，这些新型波形能够在缓解疼痛的同时，避免许多患者经历的不适感，例如麻木和感觉异常。此外，它们已被证明能够有效控制更多类型的疼痛。最终，FBSS 患者能够获得更舒适、更有效的治疗，从而改善预后并提高生活品质。
封闭回路型自适应刺激系统：市场正朝着封闭回路型自适应刺激系统发展，这类系统利用回馈迴路即时自动调节刺激参数。这些设备能够感知患者的生理讯号，并提供个人化的刺激强度，从而最大限度地缓解疼痛，无需患者手动操作。结果是治疗效果更佳、更稳定，最终改善长期疼痛控制，提高患者满意度。
与数位医疗和远端监测的整合：一个关键趋势是将FBSS治疗设备与数位医疗平台和远端患者监护整合。这使得医生能够远端监测患者的设备使用情况、疼痛程度和活动水平，并据此调整治疗方案。患者也可以透过行动应用程式监测治疗进展，并与医疗团队交流讯息。这有助于实现更协调、数据驱动的医疗服务，促进医病沟通，并有助于提高治疗的长期效果。
个人化和标靶治疗：个人化和标靶治疗的研发正在加速推进。各公司正在设计能够刺激特定神经标靶（例如背根神经节）的设备，以更精准地治疗局部疼痛。目前，治疗重点在于制定针对每位患者特定疼痛情况的个人化治疗方案。这使得治疗模式摆脱了「一刀切」的窠臼，转而针对FBSS患者出现的各种症状提供更精准有效的治疗。

这些趋势正在将 FBSS 治疗设备转变为先进的、智慧的、高度个人化的医疗保健解决方案，从而改变市场，使其不断发展，以提供端到端、数据驱动、以患者为中心的体验，从而解决脊椎手术后疼痛综合征的复杂性和长期性问题。

脊椎手术后症候群（FBSS）治疗设备市场的最新趋势

脊椎手术后症候群 (FBSS) 治疗设备市场近期呈现一系列发展趋势，正迅速推动疼痛管理领域的进步。这些趋势的核心在于技术升级、治疗适应症拓展以及策略合作的融合。其目标是开发更有效率、创伤更小、与整个医疗保健系统更紧密整合的产品和服务，从而改善患者预后并简化治疗流程。

FDA核准高频脊髓刺激系统：近期FDA核准高频脊髓刺激（SCS）系统是一项重大进展。这些新型设备，包括采用10 kHz刺激的设备，已证实能够在提供更佳镇痛效果的同时，避免传统SCS系统常见的麻木感。这项创新扩大了SCS治疗的适用人群。这种疗效显着，为FBSS患者提供了一种全新、高效且舒适的治疗选择。
封闭回路型调控设备简介：近年来，封闭回路型调控设备已应用于临床治疗领域。这些系统整合了回馈机制，能够根据患者的生理需求自动感知并调节刺激强度。这使得治疗体验更加稳定和个人化，从而最大限度地缓解患者日夜疼痛。新一代智慧型装置让患者体验更加便利、高效，并提供更持久的镇痛效果。
背根神经节刺激系统简介：背根神经节（DRG）刺激系统正日益普及并广泛应用，这是一项新的进展。这些设备靶向DRG，即一组负责传递身体特定区域疼痛讯号的神经。它能够精准有效地缓解FBSS申诉常见的局部慢性疼痛。这治疗方法，可能改善部分FBSS患者的预后。
增强的远端医疗和远距监测功能：近期进展包括在用于治疗FBSS的设备中引入远端医疗和远端监测功能。新产品现已具备无线连接功能，使临床医生能够远端监测患者的疼痛程度、设备使用情况和治疗设定。这使得临床医生能够及时调整患者的治疗方案。这有助于实现更整合、数据驱动的照护模式，加强患者与临床医师之间的沟通，并促进长期治疗的成功。
新兴的再生医学方法：除了传统的器械治疗外，再生医学技术，包括干细胞疗法和富血小板血浆（PRP）疗法，在FBSS（手术失败综合征）的治疗中也得到了发展。儘管这些研究仍处于早期阶段，但其重点在于减轻导致术后疼痛的潜在组织损伤。这为FBSS治疗开闢了新的途径，旨在透过疼痛管理以外的修復受损组织来达到治疗目的。

这些进步使 FBSS 治疗设备成为基于新技术的疼痛管理系统的关键组成部分，改变了市场，该市场正在快速发展，专注于提供不仅高效，而且高度整合、个人化且能让更多患者获得的解决方案。

北美脊椎手术后症候群 (FBSS) 治疗器械市场（按类型划分）
北美脊椎手术后症候群 (FBSS) 治疗设备市场（按应用领域划分）
美国脊椎手术后症候群（FBSS）治疗设备市场
墨西哥脊椎手术后症候群（FBSS）治疗设备市场
加拿大脊椎手术后症候群（FBSS）治疗设备市场

8. 欧洲脊椎手术后症候群 (FBSS) 治疗器械市场

欧洲脊椎手术后症候群 (FBSS) 治疗设备市场（按类型划分）
欧洲脊椎手术后症候群 (FBSS) 治疗设备市场（按应用领域划分）
德国脊椎手术后症候群（FBSS）治疗设备市场
法国脊椎手术后症候群（FBSS）治疗器械市场
西班牙脊椎手术后症候群 (FBSS) 治疗设备市场
义大利脊椎手术后症候群（FBSS）治疗设备市场
英国脊椎手术后症候群（FBSS）治疗器械市场

9. 亚太地区脊椎手术后症候群（FBSS）治疗器械市场

亚太地区脊椎手术后症候群（FBSS）治疗设备市场（按类型划分）
亚太地区脊椎手术后症候群 (FBSS) 治疗设备市场（按应用领域划分）
日本脊椎手术后症候群（FBSS）治疗器械市场
印度脊椎手术后症候群（FBSS）治疗设备市场
中国脊椎手术后症候群（FBSS）治疗器械市场
韩国脊椎手术后症候群（FBSS）治疗器械市场
印尼脊椎手术后症候群（FBSS）治疗设备市场

10. 世界其他地区（ROW）脊椎手术后症候群（FBSS）治疗器械市场

ROW 脊椎手术后症候群 (FBSS) 治疗设备市场（按类型划分）
ROW 脊椎手术后症候群 (FBSS) 治疗设备市场（按应用划分）
中东脊椎手术后症候群（FBSS）治疗器械市场
南美脊椎手术后症候群（FBSS）治疗器械市场
非洲脊椎手术后症候群（FBSS）治疗设备市场

第十一章竞争分析

产品系列分析
营运整合
波特五力分析
市占率分析

第十二章：机会与策略分析

价值链分析
成长机会分析
全球脊椎手术后症候群（FBSS）治疗设备市场新兴趋势
战略分析

第十三章：价值链中主要企业的概况

竞争分析
Boston Scientific Corporation
Medtronic
Stryker Corporation
Johnson & Johnson
Avanos Medical Devices
Abbott Laboratories
Cosman Medical

第十四章附录

简介目录图表

The future of the global failed back surgery syndrome treatment device market looks promising with opportunities in the hospital and ambulatory surgery center markets. The global failed back surgery syndrome treatment device market is expected to grow with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the increasing prevalence of back pain, the rising demand for non-invasive treatments, and the growing advancements in spinal technologies.

Lucintel forecasts that, within the type category, spinal cord stimulator is expected to witness higher growth over the forecast period.
Within the application category, ambulatory surgery center is expected to witness higher growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Failed Back Surgery Syndrome Treatment Device Market

The market for the failed back surgery syndrome treatment device is drastically transforming, with some major trends changing its landscape. These are taking the market beyond the conventional pain management towards a more integrated, technology-based, and patient-focused strategy. The emphasis is on developing solutions that are not just more effective but also less invasive and more patient-specific, thus solving a complicated and difficult-to-treat clinical condition.

Minimally Invasive and Percutaneous Implantation: One of the trends is the movement towards minimally invasive and percutaneous implantation methods for devices such as spinal cord stimulators. This minimizes surgical trauma, decreases recovery time, and lessens complications compared to open surgery. Companies are creating smaller, more flexible implants that may be administered through a single tiny incision. The effect is a more tolerable and safer treatment for patients that is becoming an increasingly popular choice among doctors and patients alike, fueling wider adoption of these devices.
Advanced Neuromodulation Waveforms: A new trend is the creation of complex neuromodulation waveforms, including high-frequency and burst stimulation. These newer waveforms, as opposed to older tonic stimulation, can be delivered with pain relief without the uncomfortable tingling sensation or paresthesia associated with it in many patients. They are also proving to be effective in the management of a wider variety of pain types. The effect is an improved and more comfortable treatment for FBSS patients, resulting in improved outcomes and improved quality of life.
Closed-Loop and Adaptive Stimulation Systems: The market is shifting toward closed-loop and adaptive stimulation systems that employ a feedback loop to automatically modify stimulation parameters in real-time. These devices perceive the patient's physiological signals and provide a tailored level of stimulation to maximize the relief from pain. This obviates the patient's need to manually control the device. The result is a more effective and consistent treatment, which can result in improved long-term control of pain and patient satisfaction.
Integration with Digital Health and Remote Monitoring: Integration of FBSS treatment devices with digital health platforms and remote patient monitoring is a significant trend. This enables doctors to remotely monitor how often a patient uses a device, pain level, and activity level, and change the settings of the therapy accordingly. Patients may also monitor progress with mobile apps and exchange messages with their healthcare team. The effect is a more coordinated and data-driven care, which enhances patient-physician conversation and facilitates long-term therapy success.
Personalized and Targeted Therapies: Personalized and targeted therapies are increasingly being developed. Companies are designing devices to deliver stimulation to discrete nerve targets, like the dorsal root ganglion, in order to treat localized pain more precisely. The emphasis is on developing a treatment plan that is tailored to the individual patient's specific pain profile. The result is a more accurate and effective treatment for the varied group of symptoms experienced in FBSS, away from the one-size-fits-all model.

These trends are transforming the market by turning FBSS treatment devices into advanced, smart, and greatly individualized medical solutions. The market is evolving toward offering an end-to-end, data-based, and patient-focused experience, which is necessary to cover the complicated and long-lasting character of Failed Back Surgery Syndrome.

Recent Developments in the Failed Back Surgery Syndrome Treatment Device Market

Failed back surgery syndrome treatment device market is witnessing a series of recent advancements that are quickly pushing the pain management field forward. These trends are centered on a blend of technology upgrades, growing treatment indications, and strategic partnerships. The ambition is to develop products and services that are more efficient, less disruptive, and better connected to the rest of the healthcare system, which will enhance patient outcomes and make the treatment process simpler.

FDA Clearances for High-Frequency SCS Systems: One major development is the recent wave of FDA clearances for high-frequency spinal cord stimulation (SCS) systems. These new devices, including devices that utilize 10 kHz stimulation, are established as being able to deliver better pain relief without the paresthesia commonly related to conventional SCS systems. This innovation is increasing the population of patients eligible for SCS therapy. The effect is a very significant contribution to pain relief, providing a new, very effective, and comfortable therapeutic option for FBSS patients.
Introduction of Closed-Loop Neuromodulation Devices: The industry recently witnessed the introduction of closed-loop neuromodulation devices. This system incorporates a feedback mechanism that automatically feels and adjusts stimulation according to a patient's physiological requirements. This delivers a more stable and individualized therapy experience, maximizing pain relief during the day and evening. The result is a new generation of smart devices that make the patient's experience easier and more effective, long-lasting pain relief.
Introduction of Dorsal Root Ganglion Stimulation Systems: A new development is the increasing availability and usage of dorsal root ganglion (DRG) stimulation systems. What this device does is target the DRG, a group of nerves that carry pain signals from one region of the body. This delivers extremely targeted and concentrated relief for patients with localized chronic pain, which is an everyday complaint of FBSS. The effect is a more targeted treatment modality for select patterns of pain, which can translate to improved results for a subpopulation of FBSS patients.
Increased Telehealth and Remote Monitoring Capabilities: Recent advances have involved the establishment of telehealth and remote monitoring capabilities for devices used in treating FBSS. New devices come to market with wireless connectivity permitting physicians to monitor a patient's level of pain, use of device, and therapy settings remotely. This allows clinicians to make timely changes to a patient's treatment plan. The effect is a more integrated and data-informed style of care, which enhances patient-physician communication and facilitates long-term therapy success.
Emergence of Regenerative Medicine Methods: There has been an evolution in the application of regenerative medicine methods, including stem cell therapy and platelet-rich plasma, along with conventional devices for FBSS management. Though in the infancy stage, this study focuses on alleviating the root tissue injury that can lead to post-surgical pain. The effect is a prospect for a new FBSS treatment paradigm that, in addition to controlling the pain, seeks to heal the injured tissues.

These advances are changing the market by placing FBSS treatment devices as a vital piece of a new, tech-based pain management system. The market is transforming fast, with an emphasis on delivering solutions that are not only efficient but also significantly integrated, tailored, and available to more patients.

Strategic Growth Opportunities in the Failed Back Surgery Syndrome Treatment Device Market

The market for failed back surgery syndrome treatment device presents a number of strategic growth opportunities based on an increased demand for sophisticated and affordable pain management options. By concentrating on these primary applications, organizations are not only able to increase their market share but also to inspire meaningful innovation in healthcare. The trick is to capitalize on the intersection of technology and healthcare in terms of solving the unique and usually complicated needs of patients with chronic post-surgical back pain.

Neuromodulation for Chronic Back and Leg Pain: The neuromodulation segment offers a significant opportunity for growth since it is the most effective and widely used therapy for FBSS. The opportunity lies in developing and selling sophisticated spinal cord stimulation (SCS) systems, such as high-frequency and burst stimulation, which are able to deliver better pain relief with lower side effects. The effect is a large market for devices that provide a long-term solution to opioids and give patients a very good quality of life.
Targeted Drug Delivery Systems for Pain Management: A second important growth opportunity exists in the design and sale of targeted drug delivery systems, including intrathecal pain pumps. These products release medication directly into the spinal fluid, with much more potent pain relief using much less dose than oral drugs. This minimizes the systemic side effects and risk of opioid addiction. The potential is to offer a highly potent remedy for non-responsive patients.
Minimally Invasive Interventional Procedures: The market provides tremendous growth opportunity in developing minimally invasive interventional procedures. This involves radiofrequency ablation devices, which are capable of blocking pain signals from individual nerves, and epidural lysis of adhesions, which can disperse scar tissue. The potential is to offer less invasive treatments that are effective in relieving specific causes of FBSS pain. The effect is a market for devices offering targeted and instantaneous pain relief with a reduced recovery period.
Remote Patient Monitoring and Telehealth Services: Remote patient monitoring and telehealth services are a large growth area. Companies can create connected devices and software platforms enabling physicians to remotely track a patient's pain and device use and set therapy settings appropriately. The opportunity here is to build a seamless ecosystem that delivers a true continuum of care, enhances patient engagement, and provides long-term therapy success.
Patient-Specific and Personalized Implants: There is an opportunity for growth in creating patient-specific and personalized implants. Through sophisticated imaging and 3D printing, firms can design implants that are customized to a specific patient's anatomy and pain profile. This can result in improved surgical outcomes as well as more efficient relief from pain. The opportunity is to offer a customized solution to a complicated condition, which can be a differentiator in a competitive market.

These opportunities are affecting the market by inducing specialization and developing high-value services. The market is shifting from a broad-based to a highly specific focus on particular applications and patient groups, which is necessary for long-term growth and innovation.

Failed Back Surgery Syndrome Treatment Device Market Driver and Challenges

The market for failed back surgery syndrome treatment device is driven by a set of strong drivers while also being challenged by some strong ones. The drivers stem from an increasing patient population, technological advancements, and a transition away from opioid-based pain relief. The challenges are associated with the high expense of high-end equipment, regulatory entanglements, and greater physician and patient education needs. A precise comprehension of these dynamics is necessary for businesses looking to understand and thrive in this intricate market.

The factors responsible for driving the failed back surgery syndrome treatment device market include:

1. Increasing Rate of Spinal Surgeries: One of the key drivers is the increasing incidence of spinal surgeries worldwide, which in turn leads to an increase in the number of patients at risk for developing FBSS. With increasing incidence of back pain due to population aging and lack of activity levels, a proportionate increase in surgical procedures is taking place, resulting in a greater base for patients to be treated for FBSS. This development translates into a stable and increasing customer base for devices used to treat chronic post-surgical pain.

2. Increasing Movement to Opioid Alternatives: The worldwide opioid epidemic is an important driver. Providers and patients alike are turning to non-opioid pain management alternatives to prevent risks of addiction and side effects. Spinal cord stimulation devices and pain pumps are an excellent, long-term alternative for managing chronic pain, so they are a very attractive option for FBSS patients.

3. Technological Advances in Neuromodulation: Leading driver is rapid technological advances. Advances in high-frequency, burst, and closed-loop stimulation systems are enhancing the efficacy and user comfort of neuromodulation systems. These advances are broadening the patient population able to be treated with these therapies and driving their acceptance among physicians looking to provide their patients with the best results.

4. Expanding Reimbursement Policies: Positive reimbursement policies in developed nations are one of the principal drivers. As government payers and insurance companies acknowledge the cost-effectiveness of long-term treatment with FBSS treatment devices over constant medical treatment and re-operations, they continue to increase their reimbursement coverage. Such reimbursement support makes these therapies more affordable for a larger patient population.

5. Growing Awareness of FBSS and Options for Treatment: There is growing awareness of FBSS as a specific clinical syndrome and greater recognition of the treatment devices that are available. Patient advocate organizations and professional medical associations are making patients and physicians aware of the condition and the variety of therapeutic approaches that are available, which is causing treatment to be provided in a more timely and effective manner.

Challenges in the failed back surgery syndrome treatment device market are:

1. Exorbitant Price of Sophisticated Devices: One of the major challenges is the exorbitant price of sophisticated FBSS treatment devices, including spinal cord stimulation systems. The prohibitive initial price of the devices and the surgery can act as an obstacle for healthcare systems and patients, particularly in areas with poor insurance coverage. This financial barrier can restrict the market penetration of these new therapies.

2. Burdensome and Complex Regulatory Process: There is a burdensome and complex regulatory process in the market. Gaining approvals from organizations such as the FDA for new innovative devices is a time-consuming and costly process that involves extensive clinical trials. This might decelerate the rate of innovation and complicate entry into the market by small companies. The process of regulation also differs significantly across countries, contributing to the complexity.

3. Physician Training and Education Requirement: One challenge is that specialized training and education for physicians are required to implant and adjust these sophisticated devices. The procedures and the device programming are intricate and need high levels of expertise. Insufficiency of trained doctors and the high learning curve involved in new technologies can be a hindrance to adoption. This also emphasizes the necessity for continued manufacturer support and training.

In conclusion, the FBSS treatment device market is growing owing to a convergence of favorable drivers such as the rise in the patient population, a decline in opioid use, and technological advancements. Its growth is, however, hindered by important constraints like device costs being very high, the presence of a complicated regulatory framework, and more physician training being required. The future of the market will rely on its capacity to overcome these challenges while also continuing to deliver efficient and patient-focused solutions for chronic pain.

List of Failed Back Surgery Syndrome Treatment Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies failed back surgery syndrome treatment device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the failed back surgery syndrome treatment device companies profiled in this report include-

Boston Scientific Corporation
Medtronic
Stryker Corporation
Johnson & Johnson
Avanos Medical Devices
Abbott Laboratories
Cosman Medical

Failed Back Surgery Syndrome Treatment Device Market by Segment

The study includes a forecast for the global failed back surgery syndrome treatment device market by type, application, and region.

Failed Back Surgery Syndrome Treatment Device Market by Type [Value from 2019 to 2031]:

Spinal Cord Stimulators
Radiofrequency Ablation Devices

Failed Back Surgery Syndrome Treatment Device Market by Application [Value from 2019 to 2031]:

Hospitals
Ambulatory Surgery Centers

Country Wise Outlook for the Failed Back Surgery Syndrome Treatment Device Market

Failed back surgery syndrome treatment device market is growing rapidly with a rising number of spinal operations and a greater percentage of patients suffering from ongoing pain after surgery. This market, ranging from spinal stimulators to pain pumps, is changing fast. New developments are targeted towards more individualized, less invasive, and better solutions to treat chronic pain. The market is also moving towards sophisticated neuromodulation technologies and increased focus on providing long-term relief to a sophisticated patient population.

United States: The United States is a prominent market, with high volume of spinal surgeries and high uptake of advanced medical devices. New products include FDA clearances of next-generation spinal cord stimulation (SCS) systems, such as those with high-frequency and burst stimulation waveforms, that deliver greater pain relief with fewer side effects. There is also significant interest in closed-loop SCS systems that adjust the stimulation automatically using real-time feedback. The market is also being pushed by emerging reimbursement policies that are increasing access to these new therapies, specifically as a non-opioid pain management option.
China: China's market is expanding sharply, driven by a huge patient base and a focused effort to modernize its healthcare infrastructure. Emerging developments are centered on domestic innovation as well as an emerging demand for advanced imported devices. Chinese firms are investing heavily in the establishment of local neuromodulation technology and minimally invasive surgical device development. Government initiatives to increase access to advanced healthcare and an increase in health consciousness are also driving growth in specialist clinics and the implementation of FBSS treatment devices.
Germany: The German market is dominated by scientific research and precision-based medical device production. Advances are focused on highly clinically tested advanced neuromodulation devices. German players are leading the development of devices that are not just effective but also have better patient safety features. The market is fueled by a high priority on long-term patient outcomes and an existing reimbursement system that favors the use of high-quality, advanced devices. There is also emphasis on research into the root causes of FBSS to make more specific therapies.
India: India's market is in its emerging stage, with recent activity concentrating on affordability and expanding access to care. The market is experiencing a mixture of high-end devices imported and an increasing number of domestically produced, cost-saving alternatives. Increased incidence of back pain and spinal procedures, as well as a rising middle class, is propelling demand. Expansion is also centered on establishing a larger network of pain clinics and the training of physicians to use novel, less invasive treatment devices.
Japan: Japan's market is characterized by strong stresses on technological advanced Ness and concern with an aging population. Recent advances involve the development of small, rechargeable spinal cord stimulation systems that are more patient-friendly. It is Japanese firms that are leading the way in embedding advanced sensors and AI in neuromodulation devices to enable tailored and adaptive treatment. The market is fueled by the aged population of the country and the resultant demand for long-term, effective remedies of chronic pain that can enhance quality of life and independence.

Features of the Global Failed Back Surgery Syndrome Treatment Device Market

Market Size Estimates: Failed back surgery syndrome treatment device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Failed back surgery syndrome treatment device market size by type, application, and region in terms of value ($B).
Regional Analysis: Failed back surgery syndrome treatment device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the failed back surgery syndrome treatment device market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the failed back surgery syndrome treatment device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the failed back surgery syndrome treatment device market by type (spinal cord stimulators and radiofrequency ablation devices), application (hospitals and ambulatory surgery centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Failed Back Surgery Syndrome Treatment Device Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Spinal Cord Stimulators: Trends and Forecast (2019-2031)
4.4 Radiofrequency Ablation Devices: Trends and Forecast (2019-2031)

5. Global Failed Back Surgery Syndrome Treatment Device Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Hospitals: Trends and Forecast (2019-2031)
5.4 Ambulatory Surgery Centers: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global Failed Back Surgery Syndrome Treatment Device Market by Region

7. North American Failed Back Surgery Syndrome Treatment Device Market

7.1 Overview
7.2 North American Failed Back Surgery Syndrome Treatment Device Market by Type
7.3 North American Failed Back Surgery Syndrome Treatment Device Market by Application
7.4 United States Failed Back Surgery Syndrome Treatment Device Market
7.5 Mexican Failed Back Surgery Syndrome Treatment Device Market
7.6 Canadian Failed Back Surgery Syndrome Treatment Device Market

8. European Failed Back Surgery Syndrome Treatment Device Market

8.1 Overview
8.2 European Failed Back Surgery Syndrome Treatment Device Market by Type
8.3 European Failed Back Surgery Syndrome Treatment Device Market by Application
8.4 German Failed Back Surgery Syndrome Treatment Device Market
8.5 French Failed Back Surgery Syndrome Treatment Device Market
8.6 Spanish Failed Back Surgery Syndrome Treatment Device Market
8.7 Italian Failed Back Surgery Syndrome Treatment Device Market
8.8 United Kingdom Failed Back Surgery Syndrome Treatment Device Market

9. APAC Failed Back Surgery Syndrome Treatment Device Market

9.1 Overview
9.2 APAC Failed Back Surgery Syndrome Treatment Device Market by Type
9.3 APAC Failed Back Surgery Syndrome Treatment Device Market by Application
9.4 Japanese Failed Back Surgery Syndrome Treatment Device Market
9.5 Indian Failed Back Surgery Syndrome Treatment Device Market
9.6 Chinese Failed Back Surgery Syndrome Treatment Device Market
9.7 South Korean Failed Back Surgery Syndrome Treatment Device Market
9.8 Indonesian Failed Back Surgery Syndrome Treatment Device Market

10. ROW Failed Back Surgery Syndrome Treatment Device Market

10.1 Overview
10.2 ROW Failed Back Surgery Syndrome Treatment Device Market by Type
10.3 ROW Failed Back Surgery Syndrome Treatment Device Market by Application
10.4 Middle Eastern Failed Back Surgery Syndrome Treatment Device Market
10.5 South American Failed Back Surgery Syndrome Treatment Device Market
10.6 African Failed Back Surgery Syndrome Treatment Device Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Failed Back Surgery Syndrome Treatment Device Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Boston Scientific Corporation
- Company Overview
- Failed Back Surgery Syndrome Treatment Device Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 Medtronic
- Company Overview
- Failed Back Surgery Syndrome Treatment Device Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Stryker Corporation
- Company Overview
- Failed Back Surgery Syndrome Treatment Device Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 Johnson & Johnson
- Company Overview
- Failed Back Surgery Syndrome Treatment Device Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 Avanos Medical Devices
- Company Overview
- Failed Back Surgery Syndrome Treatment Device Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.7 Abbott Laboratories
- Company Overview
- Failed Back Surgery Syndrome Treatment Device Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.8 Cosman Medical
- Company Overview
- Failed Back Surgery Syndrome Treatment Device Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

简介目录图表

List of Figures

Figure 1.1: Trends and Forecast for the Global Failed Back Surgery Syndrome Treatment Device Market
Figure 2.1: Usage of Failed Back Surgery Syndrome Treatment Device Market
Figure 2.2: Classification of the Global Failed Back Surgery Syndrome Treatment Device Market
Figure 2.3: Supply Chain of the Global Failed Back Surgery Syndrome Treatment Device Market
Figure 3.1: Driver and Challenges of the Failed Back Surgery Syndrome Treatment Device Market
Figure 3.2: PESTLE Analysis
Figure 3.3: Patent Analysis
Figure 3.4: Regulatory Environment
Figure 4.1: Global Failed Back Surgery Syndrome Treatment Device Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Failed Back Surgery Syndrome Treatment Device Market ($B) by Type
Figure 4.3: Forecast for the Global Failed Back Surgery Syndrome Treatment Device Market ($B) by Type
Figure 4.4: Trends and Forecast for Spinal Cord Stimulators in the Global Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Figure 4.5: Trends and Forecast for Radiofrequency Ablation Devices in the Global Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Figure 5.1: Global Failed Back Surgery Syndrome Treatment Device Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Failed Back Surgery Syndrome Treatment Device Market ($B) by Application
Figure 5.3: Forecast for the Global Failed Back Surgery Syndrome Treatment Device Market ($B) by Application
Figure 5.4: Trends and Forecast for Hospitals in the Global Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Figure 5.5: Trends and Forecast for Ambulatory Surgery Centers in the Global Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Figure 6.1: Trends of the Global Failed Back Surgery Syndrome Treatment Device Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Failed Back Surgery Syndrome Treatment Device Market ($B) by Region (2025-2031)
Figure 7.1: North American Failed Back Surgery Syndrome Treatment Device Market by Type in 2019, 2024, and 2031
Figure 7.2: Trends of the North American Failed Back Surgery Syndrome Treatment Device Market ($B) by Type (2019-2024)
Figure 7.3: Forecast for the North American Failed Back Surgery Syndrome Treatment Device Market ($B) by Type (2025-2031)
Figure 7.4: North American Failed Back Surgery Syndrome Treatment Device Market by Application in 2019, 2024, and 2031
Figure 7.5: Trends of the North American Failed Back Surgery Syndrome Treatment Device Market ($B) by Application (2019-2024)
Figure 7.6: Forecast for the North American Failed Back Surgery Syndrome Treatment Device Market ($B) by Application (2025-2031)
Figure 7.7: Trends and Forecast for the United States Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 7.8: Trends and Forecast for the Mexican Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Canadian Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 8.1: European Failed Back Surgery Syndrome Treatment Device Market by Type in 2019, 2024, and 2031
Figure 8.2: Trends of the European Failed Back Surgery Syndrome Treatment Device Market ($B) by Type (2019-2024)
Figure 8.3: Forecast for the European Failed Back Surgery Syndrome Treatment Device Market ($B) by Type (2025-2031)
Figure 8.4: European Failed Back Surgery Syndrome Treatment Device Market by Application in 2019, 2024, and 2031
Figure 8.5: Trends of the European Failed Back Surgery Syndrome Treatment Device Market ($B) by Application (2019-2024)
Figure 8.6: Forecast for the European Failed Back Surgery Syndrome Treatment Device Market ($B) by Application (2025-2031)
Figure 8.7: Trends and Forecast for the German Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 8.8: Trends and Forecast for the French Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the Spanish Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Italian Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the United Kingdom Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 9.1: APAC Failed Back Surgery Syndrome Treatment Device Market by Type in 2019, 2024, and 2031
Figure 9.2: Trends of the APAC Failed Back Surgery Syndrome Treatment Device Market ($B) by Type (2019-2024)
Figure 9.3: Forecast for the APAC Failed Back Surgery Syndrome Treatment Device Market ($B) by Type (2025-2031)
Figure 9.4: APAC Failed Back Surgery Syndrome Treatment Device Market by Application in 2019, 2024, and 2031
Figure 9.5: Trends of the APAC Failed Back Surgery Syndrome Treatment Device Market ($B) by Application (2019-2024)
Figure 9.6: Forecast for the APAC Failed Back Surgery Syndrome Treatment Device Market ($B) by Application (2025-2031)
Figure 9.7: Trends and Forecast for the Japanese Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 9.8: Trends and Forecast for the Indian Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Chinese Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the South Korean Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the Indonesian Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 10.1: ROW Failed Back Surgery Syndrome Treatment Device Market by Type in 2019, 2024, and 2031
Figure 10.2: Trends of the ROW Failed Back Surgery Syndrome Treatment Device Market ($B) by Type (2019-2024)
Figure 10.3: Forecast for the ROW Failed Back Surgery Syndrome Treatment Device Market ($B) by Type (2025-2031)
Figure 10.4: ROW Failed Back Surgery Syndrome Treatment Device Market by Application in 2019, 2024, and 2031
Figure 10.5: Trends of the ROW Failed Back Surgery Syndrome Treatment Device Market ($B) by Application (2019-2024)
Figure 10.6: Forecast for the ROW Failed Back Surgery Syndrome Treatment Device Market ($B) by Application (2025-2031)
Figure 10.7: Trends and Forecast for the Middle Eastern Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 10.8: Trends and Forecast for the South American Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the African Failed Back Surgery Syndrome Treatment Device Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global Failed Back Surgery Syndrome Treatment Device Market
Figure 11.2: Market Share (%) of Top Players in the Global Failed Back Surgery Syndrome Treatment Device Market (2024)
Figure 12.1: Growth Opportunities for the Global Failed Back Surgery Syndrome Treatment Device Market by Type
Figure 12.2: Growth Opportunities for the Global Failed Back Surgery Syndrome Treatment Device Market by Application
Figure 12.3: Growth Opportunities for the Global Failed Back Surgery Syndrome Treatment Device Market by Region
Figure 12.4: Emerging Trends in the Global Failed Back Surgery Syndrome Treatment Device Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Failed Back Surgery Syndrome Treatment Device Market by Type and Application
Table 1.2: Attractiveness Analysis for the Failed Back Surgery Syndrome Treatment Device Market by Region
Table 1.3: Global Failed Back Surgery Syndrome Treatment Device Market Parameters and Attributes
Table 3.1: Trends of the Global Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 3.2: Forecast for the Global Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global Failed Back Surgery Syndrome Treatment Device Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 4.4: Trends of Spinal Cord Stimulators in the Global Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 4.5: Forecast for Spinal Cord Stimulators in the Global Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 4.6: Trends of Radiofrequency Ablation Devices in the Global Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 4.7: Forecast for Radiofrequency Ablation Devices in the Global Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global Failed Back Surgery Syndrome Treatment Device Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 5.4: Trends of Hospitals in the Global Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 5.5: Forecast for Hospitals in the Global Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 5.6: Trends of Ambulatory Surgery Centers in the Global Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 5.7: Forecast for Ambulatory Surgery Centers in the Global Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 7.1: Trends of the North American Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 7.2: Forecast for the North American Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Application in the North American Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Application in the North American Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 8.1: Trends of the European Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 8.2: Forecast for the European Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Application in the European Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Application in the European Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 8.7: Trends and Forecast for the German Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 8.8: Trends and Forecast for the French Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 9.1: Trends of the APAC Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 9.2: Forecast for the APAC Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Application in the APAC Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Application in the APAC Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 10.1: Trends of the ROW Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 10.2: Forecast for the ROW Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Application in the ROW Failed Back Surgery Syndrome Treatment Device Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Application in the ROW Failed Back Surgery Syndrome Treatment Device Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 10.9: Trends and Forecast for the African Failed Back Surgery Syndrome Treatment Device Market (2019-2031)
Table 11.1: Product Mapping of Failed Back Surgery Syndrome Treatment Device Suppliers Based on Segments
Table 11.2: Operational Integration of Failed Back Surgery Syndrome Treatment Device Manufacturers
Table 11.3: Rankings of Suppliers Based on Failed Back Surgery Syndrome Treatment Device Revenue
Table 12.1: New Product Launches by Major Failed Back Surgery Syndrome Treatment Device Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Failed Back Surgery Syndrome Treatment Device Market

02-2729-4219

+886-2-2729-4219

License/价格

脊椎手术后症候群（FBSS）治疗设备市场报告：趋势、预测和竞争分析（至2031年）

Failed Back Surgery Syndrome Treatment Device Market Report: Trends, Forecast and Competitive Analysis to 2031